Latest Content

Sanita Burgic, of Washington University Siteman Cancer Center, combines clinical excellence and deep empathy to support cancer patients and elevate her entire oncology team.

Dr. Priscilla Merriam discusses how sarcomas can be mistaken for benign growths like lipomas and fibroids, and why asking about a biopsy can matter before surgery.

Lung cancer advocate Katie shares how losing her father to the disease and her own cancer journey inspire her work with LiveLung today.

Multiple myeloma and breast cancer survivor Valerie Traynham shares why survivorship begins at diagnosis and offers hope, resilience and life after cancer insights.

An oncologist explains why the choice between removing one lobe or the whole thyroid should be a conversation, not a surprise.

Noreen Walsh, RN, MSN, OCN, of St. Francis Hospital and Cancer Institute, builds deep personal bonds with cancer patients and families that extend far beyond clinical care.

Dr. Robert S. Alter discusses what to ask before thyroid surgery, why "active surveillance" isn't passive and how targeted therapy is changing outcomes.

At least half of patients get nervous before a follow-up scan. Dr. Geoffrey Pelz explains why that is common, what he wants patients to hear at the first visit and how much lung cancer treatment has shifted in 15 years.

FDA approves Tudriqev plus Opdivo for adults with advanced melanoma that progressed after PD-1 immunotherapy, expanding treatment options.

An incidental CT scan revealed stage 1A lung cancer. After robotic surgery at Hackensack University Medical Center, Carolyn Rothfeld describes a recovery that took longer than she expected.

After receiving a stage 1 lung cancer diagnosis, Carolyn Rothfeld underwent robotic surgery to remove part of her lung and is back to her exercise routine nine months later.

After breast cancer, one survivor reflects on reclaiming her life by remodeling her kitchen and embracing the freedom to focus on something beyond cancer.

High-risk multiple myeloma is identified through bone marrow testing and can help guide treatment decisions, from combination therapy to clinical trials.